Wznowa czerniaka z mutacją BRA F V600E z gwałtowną progresją u 40-letniej ciężarnej

Marek Michał Kluza; Katarzyna Kluza; Anna Bogaczyk; Agnieszka Pomykacz-Dworak; Agnieszka Krawczak; Tomasz Kluz

doi:10.48269/2451-0858-pis-2025-2-008

Opublikowane: 2025-12-31

Tom 25 Nr 2 (2025)

Wznowa czerniaka z mutacją BRA F V600E z gwałtowną progresją u 40-letniej ciężarnej

Marek Michał Kluza

, Katarzyna Kluza

, Anna Bogaczyk

, Agnieszka Pomykacz-Dworak

, Agnieszka Krawczak

, Tomasz Kluz

Dział: Nauki o zdrowiu

https://doi.org/10.48269/2451-0858-pis-2025-2-008

Abstrakt

W artykule opisano przypadek 40-letniej pacjentki, u której w 30. tygodniu ciąży rozpoznano zaawansowaną wznowę czerniaka z mutacją BRAF V600E. Stan ogólny pacjentki, odchylenia w badaniach laboratoryjnych oraz współistnienie przewlekłego zespołu wykrzepiania wewnątrznaczyniowego zdecydowały o zakończeniu ciąży drogą cięcia cesarskiego w 31. tygodniu ciąży. Z powodu szybkiej progresji choroby pacjentka zmarła w 25. dniu po urodzeniu zdrowego dziecka.

Słowa kluczowe:

czerniak , ciąża , mutacja BRAF 600 , wznowa , przerzuty

Pobierz pliki

PDF

Zasady cytowania

Kluza, Marek Michał, i in. „Wznowa Czerniaka Z Mutacją BRA F V600E Z gwałtowną Progresją U 40-Letniej ciężarnej”. Państwo I Społeczeństwo, t. 25, nr 2, grudzień 2025, s. 105-13, doi:10.48269/2451-0858-pis-2025-2-008.

Cited by / Share

Licencja

Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa – Użycie niekomercyjne – Bez utworów zależnych 4.0 Międzynarodowe.

Bibliografia

Ahmed B, Qadir MI, Ghafoor S. Malignant Melanoma: Skin Cancer-Diagnosis, Prevention, and Treatment. Crit Rev Eukaryot Gene Expr. 2020; 30(4): 291–297, https://doi.org/10.1615/CritRevEukaryotGeneExpr.2020028454.
Google Scholar

Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, Cust AE, de Vries E, Whiteman DC, Bray F. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol. 2022; 158(5): 495–503, https://doi.org/10.1001/jamadermatol.2022.0160.
Google Scholar

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3): 209–249, https://doi.org/10.3322/caac.21660.
Google Scholar

Kim SY, Kim SN, Hahn HJ, Lee YW, Choe YB, Ahn KJ. Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma. J Am Acad Dermatol. 2015; 72(6): 1036–1046.e2, https://doi.org/10.1016/j.jaad.2015.02.1113.
Google Scholar

Castellani G, Buccarelli M, Arasi MB, Rossi S, Pisanu ME, Bellenghi M, Lintas C, Tabolacci C. BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers. Cancers. 2023; 15(16): 4026, https://doi.org/10.3390/cancers15164026.
Google Scholar

Sandru A, Voinea S, Panaitescu E, Blidaru A. Survival rates of patients with metastatic malignant melanoma. J Med Life. 2014; 7(4): 572–576.
Google Scholar

Salvini C, Scarfì F, Fabroni C, Taviti F. Melanoma and pregnancy. G Ital Dermatol Venereol. 2017; 152(3): 274–285, https://doi.org/10.23736/S0392-0488.17.05558-4.
Google Scholar

Salani R, Billingsley CC, Crafton SM. Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstet Gynecol. 2014; 211(1): 7–14, https://doi.org/10.1016/j.ajog.2013.12.002.
Google Scholar

Pavlidis N, Pentheroudakis G. Metastatic involvement of placenta and foetus in pregnant women with cancer. Recent Results Cancer Res. 2008; 178: 183–194, https://doi.org/10.1007/978-3-540-71274-9_16.
Google Scholar

Alexander A, Samlowski WE, Grossman D, Bruggers CS, Harris RM, Zone JJ, Noyes RD, Bowen GM, Leachman SA. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol. 2003; 21(11): 2179–2186, https://doi.org/10.1200/JCO.2003.12.149.
Google Scholar

Khazzaka A, Rassy E, Sleiman Z, Boussios S, Pavlidis N. Systematic review of fetal and placental metastases among pregnant patients with cancer. Cancer Treat Rev. 2022; 104: 102356, https://doi.org/10.1016/j.ctrv.2022.102356.
Google Scholar

Peccatori FA, Azim HA Jr, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V, Pentheroudakis G; ESMO Guidelines Working Group. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24 Suppl 6: vi160–170, https://doi.org/10.1093/annonc/mdt199.
Google Scholar

Lens MB, Rosdahl I, Ahlbom A, Farahmand BY, Synnerstad I, Boeryd B, Newton Bishop JA. Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol. 2004; 22(21): 4369–4375, https://doi.org/10.1200/JCO.2004.02.096.
Google Scholar

Byrom L, Olsen CM, Knight L, Khosrotehrani K, Green AC. Does pregnancy after a diagnosis of melanoma affect prognosis? Systematic review and meta-analysis. Dermatol Surg. 2015; 41(8): 875–882, https://doi.org/10.1097/DSS.0000000000000406.
Google Scholar

de Haan J, Lok CA, de Groot CJ, Crijns MB, Van Calsteren K, Dahl Steffensen K, Halaska MJ, Altintas S, Boere IA, Fruscio R, Kolawa W, Witteveen PO, Amant F; International Network on Cancer, Infertility and Pregnancy (INCIP). Melanoma during pregnancy: a report of 60 pregnancies complicated by melanoma. Melanoma Res. 2017; 27(3): 218–223, https://doi.org/10.1097/CMR.0000000000000327.
Google Scholar

Davidson TM, Hieken TJ, Glasgow AE, Habermann EB, Yan Y. Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020. Melanoma Res. 2024; 34(2): 175–181, https://doi.org/10.1097/CMR.0000000000000953.
Google Scholar

Khosrotehrani K, Nguyen Huu S, Prignon A, Avril M-F, Boitier F, Oster M, Mortier L, Richard M-A, Maubec E, Kerob D, Mansard S, Merheb C, Moguelet P, Nassar D, Guégan S, Aractingi S. Pregnancy promotes melanoma metastasis through enhanced lymphangiogenesis. Am J Pathol. 2011; 178(4): 1870–1880, https://doi.org/10.1016/j.ajpath.2010.12.044.
Google Scholar

Rinderknecht M, Detmar M. Tumor lymphangiogenesis and melanoma metastasis. J Cell Physiol. 2008; 216(2): 347–354, https://doi.org/10.1002/jcp.21494.
Google Scholar

Prithviraj P, Anaka M, McKeown SJ, Permezel M, Walkiewicz M, Cebon J, Behren A, Jayachandran A. Pregnancy associated plasma protein-A links pregnancy and
Google Scholar

melanoma progression by promoting cellular migration and invasion. Oncotarget. 2015; 6(18): 15953–15965, https://doi.org/10.18632/oncotarget.3643.
Google Scholar

Guo Y, Bao Y, Guo D, Yang W. Pregnancy-associated plasma protein a in cancer: expression, oncogenic functions and regulation. Am J Cancer Res. 2018; 8(6):955–963.
Google Scholar

Laursen LS, Overgaard MT, Søe R, Boldt HB, Sottrup-Jensen L, Giudice LC, Conover CA, Oxvig C. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett. 2001; 504(1–2):36–40, https://doi.org/10.1016/s0014-5793(01)02760-0.
Google Scholar

Lacal PM, Failla CM, Pagani E, Odorisio T, Schietroma C, Falcinelli S, Zambruno G, D’Atri S. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J Invest Dermatol. 2000; 115(6):1000–1007, https://doi.org/10.1046/j.1523-1747.2000.00199.x.
Google Scholar

Ruffini F, Levati L, Graziani G, Caporali S, Atzori MG, D’Atri S, Lacal PM. Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1. Oncotarget. 2017; 8(40): 66833–66848, https://doi.org/10.18632/oncotarget.18706.
Google Scholar

Lens M, Bataille V. Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues. Cancer Causes Control. 2008; 19(5): 437–442, https://doi.org/10.1007/s10552-008-9110-4.
Google Scholar

Bhari N, Schwaertz RA, Apalla Z, Salerni G, Akay BN, Patil A, Grabbe S, Goldust M. Effect of estrogen in malignant melanoma. J Cosmet Dermatol. 2022; 21(5):1905–1912, https://doi.org/10.1111/jocd.14391.
Google Scholar

Barone I, Brusco L, Fuqua SAW. Estrogen receptor mutations and changes in downstream gene expression and signaling. Clin Cancer Res. 2010; 16(10): 2702–2708, https://doi.org/10.1158/1078-0432.CCR-09-1753.
Google Scholar

Marzagalli M, Montagnani Marelli M, Casati L, Fontana F, Moretti RM, Limonta P. Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility. Front Endocrinol. 2016; 7: 140, https://doi.org/10.3389/fendo.2016.00140.
Google Scholar

Rampen FH. Sex differences in survival from cutaneous melanoma. Int J Dermatol. 1984; 23(7): 444–452, https://doi.org/10.1111/ijd.1984.23.7.444.
Google Scholar

Meier F, Will S, Ellwanger U, Schlagenhauff B, Schittek B, Rassner G, Garbe C. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol. 2002; 147(1): 62–70, https://doi.org/10.1046/j.1365-2133.2002.04867.x.
Google Scholar

Schmidt AN, Nanney LB, Boyd AS, King LE Jr, Ellis DL. Oestrogen receptor-beta expression in melanocytic lesions. Exp Dermatol. 2006; 15(12): 971–980, https://doi.org/10.1111/j.1600-0625.2006.00502.x.
Google Scholar

de Giorgi V, Sestini S, Gori A, Mazzotta C, Grazzini M, Rossari S, Mavilia C, Crocetti E, Brandi ML, Lotti T, Massi D. Polymorphisms of estrogen receptors: risk factors for invasive melanoma – a prospective study. Oncology. 2011; 80(3–4): 232–237, https://doi.org/10.1159/000328321.
Google Scholar

Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol. 2017; 17(8): 469–482, https://doi.org/10.1038/nri.2017.64.
Google Scholar

Nevala WK, Vachon CM, Leontovich AA, Scott CG, Thompson MA, Markovic SN; Melanoma Study Group of the Mayo Clinic Cancer Center. Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma. Clin Cancer Res. 2009; 15(6): 1931–1939, https://doi.org/10.1158/1078-0432.CCR-08-1980.
Google Scholar

Huang N, Chi H, Qiao J. Role of Regulatory T Cells in Regulating Fetal-Maternal Immune Tolerance in Healthy Pregnancies and Reproductive Diseases. Front Immunol. 2020; 11: 1023, https://doi.org/10.3389/fimmu.2020.01023.
Google Scholar

Ziogas DC, Diamantopoulos P, Benopoulou O, Anastasopoulou A, Bafaloukos D, Stratigos AJ, Kirkwood JM, Gogas H. Prognosis and Management of BRAF V600E-Mutated Pregnancy-Associated Melanoma. Oncologist. 2020; 25(8): e1209–e1220, https://doi.org/10.1634/theoncologist.2019-0747.
Google Scholar